A smartphone-based cough screening tool is getting attention after helping identify potential tuberculosis cases in Andhra Pradesh. The tool uses AI to analyse cough sounds recorded on a phone and flag people who may need confirmatory testing. It does not replace doctors or lab tests, but it could become a faster first-level screening method in areas where healthcare access is limited.
The Andhra Pradesh pilot is important because TB often spreads silently, especially when people delay testing or ignore mild symptoms. Reports say the AI-powered Swaasa platform, developed by Hyderabad-based Salcit Technologies, was used in rural screening with support from the Andhra Pradesh government and the Ratan Tata Innovation Hub.

How Does This Cough Test Work?
The system records a person’s cough through a smartphone and analyses sound patterns using machine learning. The app compares the cough signal with patterns linked to respiratory conditions and then flags high-risk individuals for further medical testing. This is screening, not final diagnosis, and that difference matters.
According to reports, frontline workers collected cough samples during door-to-door screening in East Godavari. High-risk cases were then sent for confirmatory tests such as NAAT, chest X-rays and spirometry, which is the correct medical pathway.
| Feature | What It Means |
|---|---|
| Tool type | AI-based cough screening |
| Device needed | Smartphone with app/software |
| Main use | Flag potential TB risk |
| Location reported | Rural Andhra Pradesh |
| Final confirmation | NAAT, X-ray or other medical tests |
| Biggest benefit | Faster screening in low-access areas |
Why Is This A Big Deal For India?
India still carries one of the world’s biggest TB burdens. The WHO Global Tuberculosis Report 2025 says TB remains a major global public health issue, and Indian government data has repeatedly highlighted the need for faster detection and treatment under the National TB Elimination Programme.
This is exactly why cough-based AI tools are exciting. A village health worker can screen many people faster than waiting for every person to visit a hospital. The hard truth is that diseases like TB do not wait for perfect hospital access. If screening can move closer to homes, India gets a better chance of finding cases earlier.
What Did The Andhra Pilot Show?
Reports on the Andhra pilot say nearly 8,000 people were screened over six weeks in East Godavari using the AI cough tool. The screening reportedly found potential TB cases, and around 36% of identified TB cases were asymptomatic, meaning they did not show obvious symptoms.
That asymptomatic figure is the real attention-grabber. If people without obvious symptoms can still be flagged for testing, public health teams may catch cases earlier. But let’s not oversell it: a pilot success does not automatically mean nationwide readiness. Accuracy, cost, training, privacy and false positives must be handled properly.
What Are The Real Benefits?
The biggest benefit is reach. In rural India, many people do not get tested early because hospitals are far, symptoms look mild, or stigma stops them from coming forward. A phone-based tool can reduce the first barrier by making screening easier, faster and more portable.
Possible benefits include:
- Faster first-level TB screening in villages
- Less dependence on hospital visits for initial risk checks
- Better use of frontline health workers
- Earlier detection of people with mild or hidden symptoms
- More targeted use of confirmatory lab tests
- Useful data for public health planning
What Are The Risks?
The biggest risk is people misunderstanding the tool. A cough app cannot declare someone TB-positive with final certainty. If a result is high-risk, the person must still undergo proper medical testing. If a result is low-risk but symptoms continue, the person should still consult a doctor.
There are also serious questions around data privacy, audio storage, consent and accuracy across languages, ages, environments and phone quality. Health-tech hype can become dangerous if people start trusting apps more than medical systems. The tool is useful only when integrated into public healthcare, not when treated like a magic diagnosis button.
Conclusion?
The smartphone cough test is a promising step in India’s fight against TB because it brings screening closer to people. Andhra Pradesh’s pilot shows how AI, smartphones and frontline health workers can work together to identify high-risk cases faster, especially in rural areas where access is often weak.
But the honest conclusion is clear: this is not a replacement for doctors or lab confirmation. It is a screening tool that can help decide who needs further testing. If India uses it responsibly with consent, privacy and medical follow-up, cough-based AI could become a serious public health weapon against TB.
FAQs
Can A Smartphone Cough Test Confirm TB?
No, a smartphone cough test cannot finally confirm TB. It can only screen for possible risk and flag people who should undergo confirmatory tests such as NAAT, chest X-ray or other doctor-recommended investigations.
What Happened In The Andhra Pradesh TB Pilot?
In Andhra Pradesh, an AI-based cough screening tool was reportedly used in rural areas to identify potential TB cases. Frontline workers recorded cough samples, and high-risk people were sent for confirmatory testing.
Why Is AI Cough Screening Useful?
AI cough screening is useful because it can quickly identify people who may need further TB testing. It may help health workers reach villages faster and reduce delays in early detection, especially where hospitals or labs are not easily accessible.
Is The Smartphone TB Test Safe To Trust?
It is safe to use as a screening support tool, not as final medical proof. Any high-risk result should be followed by proper testing, and any continuing cough, fever, weight loss or night sweats should be checked by a qualified healthcare professional.